Trial Profile
Phase I study of CCX 832
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs CCX 832 (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- 01 Feb 2011 New trial record